Scapa distillery

Coloured Ties Capital Provides Lithium Portfolio Update and Substantial Issuer Bid Tender Deadline Update

Retrieved on: 
Tuesday, January 10, 2023
Lithium, News, Christmas, Power metal, CSE, MEDA, South Tyrol Option Agreement, Smart contract, Partnership, Tungsten, Dendrite International, Inc. v. Doe No. 3, Acquisition, Cadillac, Val-d'Or, Pennsylvania State University, Manning, FSE, Steel casing pipe, Property, ASX, Incentive stock option, PWM, Option, Iron Patriot, Metal, CAD, Pontiac, SUI, BRW, TSX Venture Exchange, QPC, Canadian Securities Exchange, Investment, Exercise, CTI, Scapa distillery, Trans-Taiga Road, Winsome, IPO, Patriot, North Main Street Commercial Historic District (Statesboro, Georgia), Multinational corporation, Security (finance), Road, Uranium, Silviculture, Lease, Life insurance, Oil, Case Lake, Superior, Kraken, Dipole

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) -  Coloured Ties Capital Inc. (TSXV: TIE) ("CTI" or the "Company") is pleased to provide the following update on the Company's lithium portfolio.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) -  Coloured Ties Capital Inc. (TSXV: TIE) ("CTI" or the "Company") is pleased to provide the following update on the Company's lithium portfolio.
  • The claims are immediately adjacent to claims currently held by Winsome Resources and Vision Lithium Inc., a TSXV listed Lithium explorer.
  • Hertz Lithium Inc. ("Hertz Lithium") - The Company currently holds 3,000,000 common shares of Hertz Lithium.
  • Shareholders who wish to tender their shares are urged to tender their shares in advance of the deadline to ensure efficient processing time.

Altair Leads Seed Funding for Xscape Photonics with $10 Million Investment

Retrieved on: 
Tuesday, December 20, 2022
Organization, Intel, MacArthur, AI, Silicon photonics, Volvo Scalable Product Architecture platform, Broadcom Inc., Silicon, Xscape, Data science, Physics, HPC, Columbia University, Applied physics, Scapa distillery, Artificial intelligence, Software, Machine learning, Video game console, Management, Medical device, Microscope

By applying innovative photonics technology, Xscape has developed a platform that connects various computing elements in an environmentally sustainable way while offering the highest possible performance.

Key Points: 
  • By applying innovative photonics technology, Xscape has developed a platform that connects various computing elements in an environmentally sustainable way while offering the highest possible performance.
  • The potential for photonics is significant as high-speed data transfer is also relevant for software that facilitates simulation, HPC, AI, and machine learning.
  • Shifting to embrace photonics will allow organizations across all sectors – including hardware, software, and product development companies – to accelerate their pace of innovation.
  • As part of the investment, Scapa will assume a seat on Xscape Photonics' board of directors and Altair will also secure a seat on the board of observers.

Altair Leads Seed Funding for Xscape Photonics with $10 Million Investment

Retrieved on: 
Tuesday, December 20, 2022
Organization, Intel, MacArthur, AI, Silicon photonics, Volvo Scalable Product Architecture platform, Broadcom Inc., Silicon, Xscape, Data science, Physics, HPC, Columbia University, Applied physics, Scapa distillery, Artificial intelligence, Software, Machine learning, Video game console, Management, Medical device, Microscope

By applying innovative photonics technology, Xscape has developed a platform that connects various computing elements in an environmentally sustainable way while offering the highest possible performance.

Key Points: 
  • By applying innovative photonics technology, Xscape has developed a platform that connects various computing elements in an environmentally sustainable way while offering the highest possible performance.
  • The potential for photonics is significant as high-speed data transfer is also relevant for software that facilitates simulation, HPC, AI, and machine learning.
  • Shifting to embrace photonics will allow organizations across all sectors – including hardware, software, and product development companies – to accelerate their pace of innovation.
  • As part of the investment, Scapa will assume a seat on Xscape Photonics' board of directors and Altair will also secure a seat on the board of observers.

SWM and ConvaTec Enter Long-Term Supply Agreement

Retrieved on: 
Monday, January 24, 2022
Scapa distillery, International, Polymer, GLOBE, Solution, Skin, Mark (given name), SWM, ConvaTec, Medtech, Partnership, Critical care, Medicine, Pharmaceutical industry

Alpharetta, GA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Schweitzer-Mauduit International, Inc. (SWM or SWM International) and ConvaTec Ltd. (ConvaTec) are pleased to announce that they have entered into a multi-year supply agreement in conjunction with their amicable resolution of pending litigation between the companies.

Key Points: 
  • Alpharetta, GA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Schweitzer-Mauduit International, Inc. (SWM or SWM International) and ConvaTec Ltd. (ConvaTec) are pleased to announce that they have entered into a multi-year supply agreement in conjunction with their amicable resolution of pending litigation between the companies.
  • John Petreanu, President Scapa Healthcare commented, We are pleased to restart this long-term commercial relationship with ConvaTec, a leader in advanced wound care and ostomy products.
  • Kevin Mason, Vice President, Global Procurement of ConvaTec, commented, SWM and ConvaTec have a shared a commitment to excellence, quality, and innovation.
  • SWM is a leading global performance materials company, focused on bringing best-in-class innovation, design, and manufacturing solutions to our customers.

SWM International’s Scapa Healthcare Business Signs Exclusive Technology Licensing Agreement for Novel Wound Care Technology with Synedgen, Inc.

Retrieved on: 
Tuesday, October 19, 2021
Defense, Cystic fibrosis, Defense Health Agency, Technology, Polymer, NYSE, SWM, Doctor of Philosophy, Skin, Gel, OTC, Scar, Research, Collagen, FDA, DARPA, CEO, Scapa distillery, GLOBE, Wound healing, Patient, Genetically modified bacteria, Inflammation, DHA, Medtech, Solution, Therapy, Pharmaceutical industry

The agreement also gives Scapa Healthcare the right to use Synedgens glycopolymer technology in conjunction with other wound care technologies.

Key Points: 
  • The agreement also gives Scapa Healthcare the right to use Synedgens glycopolymer technology in conjunction with other wound care technologies.
  • Under the terms of the agreement, Scapa Healthcare has exclusive rights over Synedgens glycopolymer technology in the field of dermal wounds and surgical care applications both over the counter and in the professional setting.
  • In April 2021, Schweitzer-Mauduit International, Inc., known as SWM International, acquired Scapa Group PLC, including the Scapa Healthcare business.
  • SWMs Scapa Healthcare business is the trusted strategic partner of choice for the worlds leading companies in advanced wound care, consumer wellness and medical device & fixation.

Altair Fuels Better Decision Making and Faster Optimization with Latest Release of Integrated Simulation and Analysis Portfolio

Retrieved on: 
Tuesday, October 5, 2021
Artificial intelligence, Computer-aided design, Efficiency, Decision-making, DOE, Solution, API, Software, The Narrative Design Explorer, Machine learning, CAD, Altair Engineering, AI, ML, CAE, KPI-driven code analysis, ALTR, HPC, Python, Parametric, Algorithm, Intelligence, Automation, Industry, Scapa distillery, Organization, Time, Medical device, 3D printing, Risk management

TROY, Mich., Oct. 5, 2021 /PRNewswire/ -- Altair (Nasdaq: ALTR), the global leader converging simulation, HPC, and AI, announced significant enhancements to its integrated portfolio of simulation and design tools. This update to Altair's simulation software suite is focused on accelerating simulation-driven design and unleashing the power of AI by embedding augmented intelligence in the broadest possible range of computer-aided engineering (CAE) tools.

Key Points: 
  • "The latest release of our simulation solutions embodies Altair's position at the sweet spot converging simulation, HPC, and AI.
  • For engineers, designers, and simulation specialists, this release fosters exploration, innovation, and collaboration," said James R. Scapa, founder and chief executive officer, Altair.
  • Simplified modeling workflows offer even faster design iterations, resulting in optimal, manufacturable designs earlier than ever in the development cycle.
  • "By supporting better decision making at the earliest possible opportunity, Altair is once again accelerating and optimizing design and manufacturing outcomes."

Altair Fuels Better Decision Making and Faster Optimization with Latest Release of Integrated Simulation and Analysis Portfolio

Retrieved on: 
Tuesday, October 5, 2021
Artificial intelligence, Computer-aided design, Efficiency, Decision-making, DOE, Solution, API, Software, The Narrative Design Explorer, Machine learning, CAD, Altair Engineering, AI, ML, CAE, KPI-driven code analysis, ALTR, HPC, Python, Parametric, Algorithm, Intelligence, Automation, Industry, Scapa distillery, Organization, Time, Medical device, 3D printing, Risk management

TROY, Mich., Oct. 5, 2021 /PRNewswire/ -- Altair (Nasdaq: ALTR), the global leader converging simulation, HPC, and AI, announced significant enhancements to its integrated portfolio of simulation and design tools. This update to Altair's simulation software suite is focused on accelerating simulation-driven design and unleashing the power of AI by embedding augmented intelligence in the broadest possible range of computer-aided engineering (CAE) tools.

Key Points: 
  • "The latest release of our simulation solutions embodies Altair's position at the sweet spot converging simulation, HPC, and AI.
  • For engineers, designers, and simulation specialists, this release fosters exploration, innovation, and collaboration," said James R. Scapa, founder and chief executive officer, Altair.
  • Simplified modeling workflows offer even faster design iterations, resulting in optimal, manufacturable designs earlier than ever in the development cycle.
  • "By supporting better decision making at the earliest possible opportunity, Altair is once again accelerating and optimizing design and manufacturing outcomes."

Scapa Healthcare Enhances Manufacturing & Innovation Capabilities at its Knoxville, TN Center of Excellence

Retrieved on: 
Tuesday, February 9, 2021
Mainland, Orkney, Scapa distillery, Scottish malt whisky

Scapa Healthcare has made significant investments in the Knoxville center of excellence to leverage the power of collaboration between our employees and customers to rapidly bring innovative new products to market, said John Petreanu, president of Scapa Healthcare.

Key Points: 
  • Scapa Healthcare has made significant investments in the Knoxville center of excellence to leverage the power of collaboration between our employees and customers to rapidly bring innovative new products to market, said John Petreanu, president of Scapa Healthcare.
  • Our customers require not only a dependable partner that provides high-quality products but also a partner that supports their innovation efforts.
  • Scapa Healthcare is the trusted strategic partner of choice for the worlds leading companies in advanced wound care, consumer wellness and medical device & fixation.
  • Our state-of-the-art facilities enable Scapa Healthcare to offer customers the whole spectrum of production services from inception through to market delivery.